IO-veckan 2022 State Of the Art
Novel biomarkers of response and toxicity to immunotherapy, Managing brain metastasis across indications, Treating GI Cancer Today – clinical case discussion/Q&A, IO combination therapy across indications – learnings from the clinic, Kliniska frågeställningar i samband med immunterapi – paneldiskussion.
Läs mer...
